For example, Zhichao Yan et al. [146] suggested that circXPO5 and GRIN2A can act as ceRNAs and compete with miR-330-5p to reduce circXPO5, which will have beneficial effects for glaucoma patients. The gene discussed is GRIN2A; the disease is glaucoma.